Bevirimat Dimeglumine
N/A
Report date: 2023/11/30 16:56:40
NME
Base Information
Drug NameBevirimat Dimeglumine
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMyrexis Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMyriad GeneticsMyrexis Inc
Active IndicationsN/A
Inactive Indications